Washington Trust’s Regenxbio RGNX Stock Holding History

Washington Trust’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-187	Closed	-$1.45K	–	841
2024 Q4	$1.45K	Hold	187	–	–	﹤0.01%	820
2024 Q3	$1.96K	Hold	187	–	–	﹤0.01%	802
2024 Q2	$2.19K	Hold	187	–	–	﹤0.01%	810
2024 Q1	$3.94K	Hold	187	–	–	﹤0.01%	764
2023 Q4	$3.36K	Hold	187	–	–	﹤0.01%	758
2023 Q3	$3.08K	Hold	187	–	–	﹤0.01%	730
2023 Q2	$3.74K	Hold	187	–	–	﹤0.01%	734
2023 Q1	$3.54K	Sell	187 -86	-32%	-$1.9K	﹤0.01%	758
2022 Q4	$6.19K	Buy	273 +86	+46%	+$1.94K	﹤0.01%	694
2022 Q3	$5K	Hold	187	–	–	﹤0.01%	719
2022 Q2	$5K	Hold	187	–	–	﹤0.01%	719
2022 Q1	$6K	Hold	187	–	–	﹤0.01%	723
2021 Q4	$6K	Hold	187	–	–	﹤0.01%	726
2021 Q3	$8K	Hold	187	–	–	﹤0.01%	811
2021 Q2	$7K	Hold	187	–	–	﹤0.01%	825
2021 Q1	$6K	Hold	187	–	–	﹤0.01%	809
2020 Q4	$8K	Hold	187	–	–	﹤0.01%	766
2020 Q3	$5K	Hold	187	–	–	﹤0.01%	801
2020 Q2	$7K	Hold	187	–	–	﹤0.01%	683
2020 Q1	$6K	Buy	+187	New	+$7.79K	﹤0.01%	737

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Washington Trust's RGNX Position: Q1 2025 in Review

Washington Trust sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 187 shares — an estimated $1.45K sold.

Washington Trust first reported a position in RGNX in Q1 2020 and held it in 20 quarters. The position peaked at $8K in Q3 2021. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.

Washington Trust reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
Washington Trust sold 187 Regenxbio shares in Q1 2025, an estimated $1.45K.
Washington Trust first reported a position in Regenxbio in Q1 2020 and held it in 20 quarters.
Washington Trust's Regenxbio position peaked at $8K in Q3 2021.
164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.

Based on Washington Trust's 13F filing for Q1 2025, filed 25 Apr 2025.